During the past decade, Swor Women's Care conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Swor Women's Care" are "Laparoscopic Gynecological Surgery" (1 trials) and "Leiomyoma" (1 trials). Many other conditions were trialed in "Swor Women's Care" in a lesser frequency.

Most popular intervention types in "Swor Women's Care" are "Device" (1 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Eximis CS (Contained Segmentation) System" (1 trials), "Standard of care" (1 trials) and "Vilaprisan (BAY1002670)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Swor Women's Care" are 2 trials for "Female" genders.

Currently, there are NaN active trials in "Swor Women's Care". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Swor Women's Care, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Swor Women's Care, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".